• Latest Posts

Five latest advancements in Tourette’s syndrome research

Noema Pharma raises $112 million in Series B financing 

Biocytogen launches nanobody therapeutics project for 100 targets

Sysnav and Roche partner on movement tracking technology

Funding for university to develop new motor neuron disease therapies

ADVERTISEMENT

Team wins $149M contract for National Institute of Neurological Disorders and Stroke

Silo Pharma looks into the 2023 psychedelics crystal ball

STALICLA signs agreement with Novartis on neurodevelopmental disorders

Watch: IRLAB CEO Richard Godfrey

Alchemab Therapeutics receives £1.7M grant to work on therapy for Huntington’s disease

Charcot-Marie-Tooth study to get $250K grant

ADVERTISEMENT